Daan Gene Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

10.58

EPS

—

Div Yield, %

0.23%

Shrs. gr., 5y

-0.02%

Rev. gr., 5y

-4.93%

Revenues

853m

-27.76%

Net income

-925m

CFO

300m

-64.49%

Dividend

Jun 14, 20240.015 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Daan Gene Co., Ltd. researches and develops, manufactures, and sells clinical test reagents and instruments. The company offers fluorescence quantitative PCR products, time resolution series products, enzyme-linked immunoassay products, instrument products, and scientific research service products. It also provides medical examination, and health consultation and management services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. The company was founded in 2001 and is headquartered in Guangzhou, the People's Republic of China.

URL

https://www.daangene.com/

IPO date

Aug 09, 2004

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT